SEC Form D private-offering filing
Prince Biotech, Inc.
A new SEC Form D private-offering notice from Mason, OH, a $10,000,000 filer-stated offering target in Biotech. The source filing is one click away.
Develops immune and regenerative medicine therapies based on Preimplantation Factor (PIF), a pregnancy derived molecule, through its subsidiary BioIncept.
Filed 2025-10-27Filed to raise $10,000,000HQ (as filed) Mason, OHSector Biotech ✓Stage (inferred) EarlyCall status No reported sale
Source linked the Form D on EDGAR↗Website verified princebiotech.com↗Named in the filing 5 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.